Literature DB >> 19013135

Delayed liver regeneration after partial hepatectomy in adiponectin knockout mice.

Hisao Ezaki1, Yuichi Yoshida, Yukiko Saji, Takayo Takemura, Juichi Fukushima, Hitoshi Matsumoto, Yoshihiro Kamada, Akira Wada, Takumi Igura, Shinji Kihara, Tohru Funahashi, Iichiro Shimomura, Shinji Tamura, Shinichi Kiso, Norio Hayashi.   

Abstract

We previously demonstrated that adiponectin has anti-fibrogenic and anti-inflammatory effects in the liver of mouse models of various liver diseases. However, its role in liver regeneration remains unclear. The aim of this study was to determine the role of adiponectin in liver regeneration. We assessed liver regeneration after partial hepatectomy in wild-type (WT) and adiponectin knockout (KO) mice. We analyzed DNA replication and various signaling pathways involved in cell proliferation and metabolism. Adiponectin KO mice exhibited delayed DNA replication and increased lipid accumulation in the regenerating liver. The expression levels of peroxisome proliferator-activated receptor (PPAR) alpha and carnitine palmitoyltransferase-1 (CPT-1), a key enzyme in mitochondrial fatty acid oxidation, were decreased in adiponectin KO mice, suggesting possible contribution of altered fat metabolism to these phenomena. Collectively, the present results highlight a new role for adiponectin in the process of liver regeneration.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19013135     DOI: 10.1016/j.bbrc.2008.10.176

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  16 in total

1.  Adiponectin fine-tuning of liver regeneration dynamics revealed through cellular network modelling.

Authors:  Jason M Correnti; Daniel Cook; Edita Aksamitiene; Aditi Swarup; Babatunde Ogunnaike; Rajanikanth Vadigepalli; Jan B Hoek
Journal:  J Physiol       Date:  2015-01-15       Impact factor: 5.182

Review 2.  Regulation of glucose and lipid homeostasis by adiponectin: effects on hepatocytes, pancreatic β cells and adipocytes.

Authors:  Caroline Tao; Angelica Sifuentes; William L Holland
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2013-11-15       Impact factor: 4.690

Review 3.  Adiponectin: a key playmaker adipocytokine in non-alcoholic fatty liver disease.

Authors:  Nikolaos K Gatselis; George Ntaios; Konstantinos Makaritsis; George N Dalekos
Journal:  Clin Exp Med       Date:  2013-01-05       Impact factor: 3.984

4.  Liver regeneration is impaired in lipodystrophic fatty liver dystrophy mice.

Authors:  Vered Gazit; Alexander Weymann; Eric Hartman; Brian N Finck; Paul W Hruz; Anatoly Tzekov; David A Rudnick
Journal:  Hepatology       Date:  2010-10-21       Impact factor: 17.425

Review 5.  Adiponectin as a tissue regenerating hormone: more than a metabolic function.

Authors:  Tania Fiaschi; Francesca Magherini; Tania Gamberi; Pietro Amedeo Modesti; Alessandra Modesti
Journal:  Cell Mol Life Sci       Date:  2013-12-10       Impact factor: 9.261

6.  Hepatic retinoid stores are required for normal liver regeneration.

Authors:  Igor O Shmarakov; Hongfeng Jiang; Kryscilla Jian Zhang Yang; Ira J Goldberg; William S Blaner
Journal:  J Lipid Res       Date:  2013-01-23       Impact factor: 5.922

7.  Pioglitazone: more than just an insulin sensitizer.

Authors:  Mark J Czaja
Journal:  Hepatology       Date:  2009-05       Impact factor: 17.425

Review 8.  Genomics of liver transplant injury and regeneration.

Authors:  Sohaib Khalid Hashmi; Esther Baranov; Ana Gonzalez; Kim Olthoff; Abraham Shaked
Journal:  Transplant Rev (Orlando)       Date:  2014-03-04       Impact factor: 3.943

9.  The Current Knowledge of the Role of PPAR in Hepatic Ischemia-Reperfusion Injury.

Authors:  M Elias-Miró; M B Jiménez-Castro; M Mendes-Braz; A Casillas-Ramírez; C Peralta
Journal:  PPAR Res       Date:  2012-05-16       Impact factor: 4.964

10.  A20 modulates lipid metabolism and energy production to promote liver regeneration.

Authors:  Scott M Damrauer; Peter Studer; Cleide G da Silva; Christopher R Longo; Haley E Ramsey; Eva Csizmadia; Gautam V Shrikhande; Salvatore T Scali; Towia A Libermann; Manoj K Bhasin; Christiane Ferran
Journal:  PLoS One       Date:  2011-03-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.